Free Trial

Anterix Inc. (ATEX) - What Are Analysts Saying About This Stock?

Anterix logo with Communication Services background
Image from MarketBeat Media, LLC.

Key Points

  • Analyst sentiment is moderately positive: Five analysts give Anterix an average “Moderate Buy” rating, with a mean 12-month price target of $120.
  • Anterix reported quarterly EPS of $0.01, beating the consensus estimate of a $0.43 loss, while revenue of $1.96 million came in slightly below the $2.00 million estimate.
  • Company insiders sold a combined 124,841 shares worth about $11.0 million during the quarter; institutional investors own 87.67% of the stock.
  • Interested in Anterix? Here are five stocks we like better.

Shares of Anterix Inc. (NASDAQ:ATEX - Get Free Report) have been assigned an average rating of "Moderate Buy" from the five analysts that are covering the company, Marketbeat reports. Three analysts have rated the stock with a hold recommendation, one has assigned a buy recommendation and one has issued a strong buy recommendation on the company. The average twelve-month price target among brokers that have covered the stock in the last year is $120.00.

Several brokerages have recently issued reports on ATEX. Clear Str raised Anterix to a "strong-buy" rating in a research note on Monday, July 27th. Wall Street Zen lowered shares of Anterix from a "hold" rating to a "sell" rating in a report on Saturday, August 15th. Weiss Ratings cut shares of Anterix from a "hold (c+)" rating to a "hold (c)" rating in a research report on Monday, October 26th. JPMorgan Chase & Co. lowered their price target on shares of Anterix from $133.00 to $130.00 and set an "overweight" rating on the stock in a research report on Thursday, August 13th. Finally, DA Davidson set a $161.00 target price on shares of Anterix in a research report on Friday, August 21st.

View Our Latest Analysis on Anterix

Anterix Trading Up 8.5%

NASDAQ:ATEX opened at $74.36 on Friday. The business's fifty day moving average price is $82.10 and its 200 day moving average price is $66.42. The firm has a market capitalization of $1.46 billion, a price-to-earnings ratio of 21.25 and a beta of 0.87. Anterix has a 1-year low of $17.58 and a 1-year high of $113.00.

Anterix (NASDAQ:ATEX - Get Free Report) last issued its quarterly earnings results on Tuesday, August 11th. The company reported $0.01 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.43) by $0.44. The company had revenue of $1.96 million for the quarter, compared to the consensus estimate of $2.00 million. Anterix had a negative return on equity of 10.65% and a net margin of 933.03%. Equities analysts forecast that Anterix will post -2.00 earnings per share for the current year.

Insider Transactions at Anterix

In other Anterix news, CFO Elena Marquez sold 4,981 shares of Anterix stock in a transaction that occurred on Friday, October 9th. The stock was sold at an average price of $80.43, for a total transaction of $400,621.83. Following the sale, the chief financial officer directly owned 12,604 shares of the company's stock, valued at approximately $1,013,739.72. The trade was a 28.33% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CMO Heather Martin sold 8,064 shares of the company's stock in a transaction that occurred on Thursday, September 10th. The stock was sold at an average price of $84.20, for a total transaction of $678,988.80. Following the completion of the transaction, the chief marketing officer owned 26,743 shares in the company, valued at approximately $2,251,760.60. This represents a 23.17% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders sold 124,841 shares of company stock worth $10,975,765. Corporate insiders own 40.05% of the company's stock.

Hedge Funds Weigh In On Anterix

A number of institutional investors and hedge funds have recently modified their holdings of ATEX. BlackRock Inc. bought a new position in Anterix in the second quarter worth about $110,672,000. Jupiter Topco LLC acquired a new position in Anterix in the second quarter valued at about $68,189,000. Gamco Investors INC. ET AL increased its position in shares of Anterix by 0.8% during the first quarter. Gamco Investors INC. ET AL now owns 425,820 shares of the company's stock worth $16,262,000 after acquiring an additional 3,350 shares during the period. Dimensional Fund Advisors LP boosted its holdings in Anterix by 30.8% in the first quarter. Dimensional Fund Advisors LP now owns 424,856 shares of the company's stock valued at $16,223,000 after purchasing an additional 99,933 shares in the last quarter. Finally, Bank of America Corp DE grew its stake in shares of Anterix by 17.2% in the 1st quarter. Bank of America Corp DE now owns 167,781 shares of the company's stock valued at $6,408,000 after purchasing an additional 24,657 shares during the last quarter. Hedge funds and other institutional investors own 87.67% of the company's stock.

Anterix Company Profile

(Get Free Report)

Anterix Inc NASDAQ: ATEX develops and provides private wireless broadband solutions for critical infrastructure industries. The company's primary focus is enabling electric, gas, water and other utilities to deploy secure, resilient communications networks that support operational technology, grid modernization and other mission-critical applications.

Anterix primarily uses its licensed 900 MHz spectrum holdings to support private broadband networks. Its offerings include spectrum access and related wireless communications solutions designed to help utilities connect field equipment, sensors, control systems and mobile workforces.

Read More

Analyst Recommendations for Anterix (NASDAQ:ATEX)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Anterix Right Now?

Before you consider Anterix, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Anterix wasn't on the list.

While Anterix currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries. "Physical AI" is coming. Learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines